
    
      The purpose of this study is to determine the safety and effectiveness of AGS-004, an immune
      therapy, for HIV-infected individuals. Safety and effectiveness will be tested while the
      individuals are both taking antiretroviral therapy (ART) medication and interrupting ART
      medication
    
  